News
🇺🇸 FDALatest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 1–12 of 823 articles
Quick answer
NovaPharmaNews United States & Americas news feed tracks 823 published stories — FDA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
Roche Gets FDA Clearance for cobas BV/CV Assay
FDA Accepts BridgeBio Encaleret NDA for ADH1
FDA Accepts Daraxonrasib NDA for Pancreatic Cancer
FDA Accepts Dyne BLA for z-Rostudirsen in DMD
FDA Approves GSK Jideytro for ROS1+ NSCLC
Drug Repurposing Stakeholders Say FDA Should Act
FDA approves Merck oral PCSK9 drug
FDA Approves New Breast Cancer Drug Revtorpyk
FDA Activity Round Up July 2026
Commissioner National Priority Voucher CNPV Pilot
Study China outpaces the US in cancer approvals
Summit Therapeutics Refocuses on Oncology Drug
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.